TrialJournal of substance abuse treatment

A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.

Adam Bisaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.